Illumina Innovation Fund II GP, L.L.C. sold ALMR
April 20, 2026 · Form 4 insider transaction
Illumina Innovation Fund II GP, L.L.C. sold 5,510,516 shares of Alamar Biosciences, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO.; The securities are held by Illumina Innovation Fund II, L.P. ("IIF II"). Illumina Innovation Fund II GP, L.L.C. ("IIF II GP") is the general partner of IIF II. Nicholas Naclerio ("Mr. Naclerio"), a member of the Issuer's board of directors, is the sole managing member of IIF II GP and may be deemed to have voting, investment and dispositive power with respect to the securities held by IIF II. Each of IIF II GP and Mr. Naclerio disclaim beneficial ownership over the securities held by IIF II, except to the extent of their respective pecuniary interests therein, if any.